Franke, Patrick: Vitamin D3-Analogon / -Cyclodextrin-Kavitate - Herstellung, Charakterisierung und In-vitro-Liberation aus Dermatika -

Literatur

1 NIEDNER R. , ZIEGENMEYER J. Dermatika , Wissenschaftliche Verlagsgesellschaft Stuttgart 1992 , SS. 287-299

2 LANDMANN L. "Die Permeabilitätsbarriere der Haut" , Pharm. unserer Zeit 20 , 155ff (1991 )

3 SAMS W.M. , LYNCH P.J. Principles and Practice of Dermatology , Churchill Livingstone New York Edinburgh 1996 , SS. 1-6

4 MOLL F. , BENDER H. Biopharmzeutische Untersuchungsverfahren , Wissenschaftliche Verlagsgesellschaft Stuttgart 1994 , S. 68

5 SHAH V.P. , BEHL C.R. , FLYNN G.L. , HIGUCHI W.I. , SCHAEFER H. "Principles and criteria in the development and optimization of topical therapeutic products" , Int. J. Pharm. 82 , 21-28 (1992 )

6 ZESCH A. "Zur Bioäquivalenz und Bioverfügbarkeit topisch applizierter Arzneimittel" , Pharm. Ind. 50 , 746-749 (1988 )

7 TAKAHACHI M. , MACHIDA Y. , MARKS R. "Measurement of turnover time of stratum corneum using dansyl chloride fluorescence" , J. Soc. Cosmet. Chem. 38 , 321-331 (1987 )

8 THEWS G. , MUTSCHLER E. , VAUPEL P. Anatomie, Physiologie un Pathophysiologie des Menschen , Wissenschaftliche Verlagsgesellschaft Stuttgart 1989 , S. 606

9 BADEN H.P. , LEE, L.D. "Fibrous Protein of Human Epidermis" , J. Invest. Dermatol. 71 , 148-151 (1978 )

10 BERNSTEIN I.A. In: Goldsmith, L.A. (Herausgeber), Biochemistry and Physiology of the Skin , Oxford University Press 1983 , SS. 170-183

11 BERNSTEIN I.A. In: Goldsmith, L.A. (Herausgeber), Biochemistry and Physiology of the Skin , Oxford University Press 1983 , SS. 184-196

12 RICE R.H. , GREEN H. "The Cornified Envelope of Terminally Differentiated Human Epidermal Keratinocytes Consists of Cross-Linked Protein" , Cell 11 , 417-422 (1977 )

13 ODLAND G.F. , HOLBROOK K.A. In: Mali, J.W.H. (Herausgeber), Current Problems in Dermatology , Karger Basel (1981 ), SS. 29-49

14 GRAY G.M. , YARDLEY H.J. "Different populations of pig epidermal cells: isolation and lipid composition" , J. Lipid Res. 16 , 441-447 (1975 )

15 GRAY G.M. , WHITE R.J. "Glycosphingolipids and Ceramides in Human and Pig Epidermis" , J. Invest. Dermatol. 70 , 336-341 (1978 )

16 WERTZ P.W. In: Bereiter-Hahn J., Matoltsy A.G., Richards K.S. (Herausgeber ), Biology of the Integument. Vol.2 , Springer Verlag Berlin 1986 , SS. 815-823

17 YARDLEY, H.J. In: Goldsmith L.A. (Herausgeber), Biochemistry and Physiology of the Skin , Oxford University Press 1983 , SS. 363-381

18 WEINSTEIN G.D. , FROST P. , HSIA S.L. "In vitro interconversion of Estrone and 17beta-Estradiol in human skin and vaginal mucosa" , J. Invest. Dermatol. 51 , 4-10 (1968 )

19 MARTIN R.J. , DENYER S.P. , HADGRAFT J. "Skin metabolism of topically applied compounds" , Int. J. Pharm. 39 , 23-32 (1987 )

20 BARRY B.W. "Mode of action of penetration enhancers in human skin" , J. Controlled Release 6 , 85-97 (1987 )

21 BLANK I.H. , SCHEUPLEIN R.J. "Transport into and within the skin" , Br. J. Dermatol. 81 , Suppl. 4, 4-10 (1969 )

22 BAUER K.H. , FRÖMMING K.H. , FÜHRER C. Pharmazeutische Technologie , Georg Thieme Verlag Stuttgart New York 1993 , S. 194

23 HOLBROOK K.A. , ODLAND G.F. "Regional differences in the thickness (cell layers) of the human stratum corneum: an ultrastructural analysis" , J. Invest. Dermatol. 62 , 415-422 (1974 )

24 ANDERSON R.L. , CASSIDY J.M. "Variations in physical dimensions and chemical composition of human stratum corneum" , J. Invest. Dermatol. 61 , 30-32 (1973 )

25 ROOK A. , WILKINSON D.S. , EBLING F.J.G. , Champion R.H. , Burton J.L. Textbook of Dermatology Vol.1 , Blackwell Scientific Publications London Edinburgh Boston (1992 ), SS. 49-50

26 NEUBERT R. , SCHMALFUß U. , WOHLRAB W. , HUSCHKA CH. "Wirkstoffpenetration in die Haut und deren Modulation" , Pharm. Ztg. 141 , 1483-1493 (1996 )

27 ZIEGENMEYER J. "Haut - Vehikel - Pharmakon, die entscheidenden Kriterien für die percutane Absorption" , Pharm. unserer Zeit 15 , 129-143 (1986 )

28 DOWNING D.T. , WERTZ P.W. , STEWART M.E. "The role of sebum and epidermal lipids in the cosmetic properties of skin" , Int. J. Cosmet. Sci. 8 , 115-123 (1986 )

29 WESTER R.C. , MAIBACH H.J. "Cutaneous Pharmacokinetics: 10 Steps to Percutaneous Absorption" , Drug Metab. Rev. 14 , 169-205 (1983 )

30 LIPPOLD B.C. "Wirkstoffresorption aus Dermatika" , Dtsch. Apoth. Ztg. 121 , 2585 ff (1981 )

31 MALLORY S.B. , LEHMAN P.A. , VANDERPOOL D.R. , FRANZ T.J. Pediatr. Dermatol. 10 , 370 (1993 ) zit. [ siehe ]

32 HADGRAFT J. , WILLIAMS D.G. , ALLAH G. In: Walters K.A., Hadgraft J. (Herausgeber ), Pharmaceutical Skin Penetration Enhancement , Marcel Dekker , New York , Basel 1993

33 SANTUS G.C. , BAKER R.W. "Transdermal enhancer patent literature" , J. Control. Rel. 25 , (1993 ) zit. [ siehe ]

34 KIM C.K. , KIM J.J. , CHI S.-C. , SHIM C.-K. "Effect of fatty acids and urea on the penetration of ketoprofen through rat skin" , Int. J. Pharm. 99 , 109 (1993 )

35 KALBITZ J. , NEUBERT R. , WOHLRAB W. "Modulation of skin drug penetration" , Parmazie 51 , 619-637 (1996 )

36 FALSON-RIEG F. , LAFFORGUE C. "Prediction of percutaneous penetration" , 4a , Ch. 40 (1995 ) zit. [ siehe ]

37 SHAH V.P. , ELKINS J. , LAM S.-Y. , SKELLY J.P. "Determination of in vitro drug release from hydrocortisone creams" , Int. J. Pharm. 53 , 53-59 (1988 )

38 KUNDU S.C. , CAMERON A.D. , MELTZER N.M. , QUICK T.W. "Development and validation of method for determination of in vitro release of retinoic acid from creams" , Drug Dev. Ind. Pharm. , 19 , 425-438 (1993 )

39 KEYHANI-MORRISON E. , NADKARNI S. , SAKR A. "Optimization of an in vitro method for evaluating the release of a novel retinoid from topical gels" , Pharm. Ind. 57 , 414-419 (1995 )

40 LOTH H. , HOLLA-BENNINGER A. "Untersuchungen der Arzneistoffliberation aus Salben" , Pharm. Ind. 40 , 256-261 (1978 )

41 FRANZ T.J. "Percutaneous absorption - Relevance of in vitro data" , J. Invest. Dermatol. 64 , 190-195 (1975 )

42 SHAH V.P. , FLYNN G.L. , GUY R.H. , MAIBACH H.I. , SCHAEFER H. , SKELLY J.P. , WESTER R. C., YACOBI A. "In vivo percutaneous penetration / absorption" , Int. J. Pharm. 74 , 1-8 (1991 )

43 DUCHÊNE D. Cyclodextrins and their industrial uses , Editions de Santé Paris , 1987 , SS. 447-460

44 GERLOCZY A. , ANTAL S. , SZEJTELI J. In: Huber O. (Herausgeber), Proceedings of the Fourth International Symposium on Cyclodextrins: Munich, West Germany, April 20-22 , 1988 , SS. 415-422 , zit. [ siehe ]

45 ARIMA H. , ADACHI H. , IRIE T. , UEKAMA K. , PITHA J. "Enhancement of the Antiinflammatory Effect of Ethyl 4-Biphenylyl Acetate in Ointment by beta-Cyclodextrin Derivates: Increased Absorption and Localized Activation of the Prodrug in Rats" , Pharm. Res. 7 , 1152-1156 (1990 )

46 OKAMOTO H. , KOMATSU H. , HASHIDA M. , SEZAKI H. "Effects of beta-Cyclodextrin and di-O-methyl-beta-cyclodextrin on the percutaneous absorption of butylparaben, indomethacin and sulfanilic acid" , Int. J. Pharm. 30 , 35-45 (1986 )

47 VOLLMER U. , MÜLLER B.W. , PEETERS J. , MESENS J. , WILFFERT B. , PETERS T. "A Study of the percutaneous absorption-enhancing effects of cyclodextrin derivatives in rats" , J. Pharm. Pharmacol. 46 , 19-22 (1994 )

48 IRIE T. , OTAGIRI M. , SUNADA M. , UEKAMA K. , OHTANI Y. , YAMADA Y. , SUGIYAMA Y. "Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro" , J. Pharm. Dyn. 5 , 741-744 (1982 )

49 FRIDRICH R. , MEHNERT W. , FRÖMMING K.-H. "Studies of the Inclusion compound between beta-Cyclodextrin and Cholesterol" , In: Hedges A.R. (Herausgeber), Minutes of the Fifth International Symposium on Cyclodextrins: Chicago, 21 to 24 April 1992 , Edition de Santé Paris 1992 , SS. 299-302

50 ARIMORI K. , SAKAI A. , OTAGIRI M. , UEKAMA K. "Improvement in biopharmaceutics of prednisolone by beta- and gamma-cyclodextrins" , J. Inclusion Phenom. 1 , 387-394 (1984 )

51 UEKAMA K. , ARIMORI K. , SAKAI A. , MASAKI K. , IRIE T. , OTAGIRI M. "Improvement in percutaneous absorption of prednisolone by beta- and gamma-cyclodextrin complexations" , Chem. Pharm. Bull. 35 , 2910-2913 (1987 )

52 UEKAMA K. , OTAGIRI M. , SAKAI A. , IRIE T. , MATSUO N. , MATSUOKA Y. "Improvement in the percutaneous absorption of beclomethasone dipropionate by gamma-Cyclodextrin complexation" , J. Pharm. Pharmacol. 37 , 532-535 (1985 )

53 PREISS A. , MEHNERT W. , FRÖMMING K.-H. "Penetration of hydrocortisone into excised human skin under the influence of cyclodextrins" , Pharmazie 50 , 121 ff (1995 )

54 OTAGIRI M. , FUJINAGA T. , SAKAI A. , UEKAMA K. "Effects of beta- and gamma-cyclodextrins on release of betamethasone from ointment bases" , Chem. Pharm. Bull. 32 , 2401-2405 (1984 )

55 FRIJLINK H.W. , EISSENS A.C. , SCHOONEN A.J.M. , LERK C.F. "The Effects of Cyclodextrins on Drug Release from Fatty Suppository Bases / I. In vitro Observations" , Eur. J. Pharm. Biopharm. 37 , 178-182 (1991 )

56 FRIJLINK H.W. , EISSENS A.C. , SCHOONEN A.J.M. , LERK C.F. "The Effects of Cyclodextrins on Drug Release from Fatty Suppository Bases / II. In vivo Observations" , Eur. J. Pharm. Biopharm. 37 , 183-187 (1991 )

57 FRIJLINK H.W. , PAIOTTI S. , EISSENS A.C. , LERK C.F. "The Effects of Cyclodextrins on Drug Release from Fatty Suppository Bases / III. Application of Cyclodextrin Derivatives" , Eur. J. Pharm. Biopharm. 38 , 174-179 (1992 )

58 IRIE T. , UEKAMA K. "Protection against the photosensitized skin irritancy of chlorpromazine by cyclodextrin complexation" , J. Pharmacobio -Dyn. 8 , 788-791 (1985 )

59 HOSHINO T. , ISHIDA K. , IRIE T. , UEKAMA K. , ONO T. "An attempt to reduce the photosensitizing potential of chlorpromazine with the simultaneous use of beta- and dimethyl-beta-cyclodextrins in guinea pigs" , Arch. Dermatol. Res. 281 , 60-65 (1989 )

60 AMDIDOUCHE D. , MONTASSIER P. , POELMAN M.-C. , DUCHÊNE D. "Evaluation by laser Doppler velocimetry of the attenuation of tretinoin induced skin irritation by beta-cyclodextrin complexation" , Int. J. Pharm. 111 , 111-116 (1994 )

61 ARIMA H. ; KONDO T. , IRIE T. , UEKAMA K. "Enhanced rectal absorption and reduced local irritation of the anti-inflammatory drug Ethyl-4-biphenylylacetate in rats by complexation with water-soluble beta-cyclodextrin derivatives and formulation as oleaginous suppository" , J. Pharm. Sci. , 81 , 1119-1125 (1992 )

62 AMDIDOUCHE D. , DARROUZET H. , DUCHÊNE D. , POELMAN M. -C."Inclusion of retinoic acid in beta-cyclodextrin" , Int. J. Pharm. 54 , 175-179 (1989 )

63 ROLLAND A. , SHROOT B. "Preparation and evaluation of dermatological formulations based on the inclusion of tretinoin in beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin " In: Hedges A.R. (Herausgeber), Minutes of the Fifth International Symposium on Cyclodextrins: Chicago, 21 to 24 April 1992 , Edition de Santé Paris 1992 , SS. 529-534

64 IRIE T. , UEKAMA K. "Pharmaceutical Applications of cyclodextrines-toxicological issues and safety evaluation" , J. Pharm. Sci. , 86 , 147-162 (1997 )

65 IRIE T. , SUNADA M. , OTAGIRI M. , UEKAMA K. "Protective mechanism of beta-cyclodextrin for the hemolysis induced with phenothiazine neuroleptics in vitro" , J. Pharm. Dyn. 6 , 408-414 (1983 )

66 UEKAMA K. , IRIE T. , OTAGIRI M. , HOSHINO T. , YAMADA Y. , OHTANI Y. "Protective effects of cyclodextrins on the hemolysis induced with imipramine in vitro" , Maku 8 , 315-321 (1983 )

67 MENTER A. , BARKER J.N.W. N."Psoriasis in practice" , Lancet 338 , 231-234 (1991 )

68 STADLER R. , OTTE H. -G. "Eine neue Alternative in der Psoriasis-Therapie: Calcipotriol, ein Vitamin-D3-Analogon. Zwei Fallberichte" , Haut und Gesundheit , Band 68 , 292-295 (1993 )

69 VAN DE KERKHOF P.C.M. "Biological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanisms" , Br. J. Dermatol. 132 , 675-682 (1995 )

70 THIEROFF-ECKERDT R. , GERHARD D. , HARTUNG A. , KRAUSE A. , WIESINGER, H. "Erythema induction by calcipotriol: a vitamin D receptor-mediated effect?" Arch. Dermatol. Res. 286 , 159 (1994 )

71 KRAGBALLE K. , WILDFANG I.L. "Calcipotriol (MC 903), a novel vitamin D3 analogue stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes" , Arch. Dermatol. Res. 282 , 164-167 (1990 )

72 MUTSCHLER E. , SCHÄFER-KORTING M. Arzneimittelwirkungen: Lehrbuch der Pharmakologie und Toxikologie , Wissenschaftliche Verlagsgesellschaft Stuttgart 1996 , S. 622

73 KRAGBALLE K. "Treatment of psoriasis by the topical application of the novel cholecalciferol analog calcipotriol" , Arch. Dermatol. Res. 125 , 1647-1652 (1989 )

74 BINDERUP L. , BRAMM E. "Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo" , Biochem. Pharmacol. 37 , 889-895 (1988 )

75 SZEJTLI J. , BOLLA-PUSZTEI É. , SZABÓ P. , FERENCZY T. "Enhancement of stability and biological effect of cholecalciferol by beta-cyclodextrin complexation" , Pharmazie 35 , 779-787 (1980 )

76 SZEJTLI J. , DAVIES J.E.D. Cyclodextrin Technology , Kluwer Academic Publishers Dordrecht Boston London 1988 , S. 83

77 OKADA Y. , KUBOTA Y. , KOIZUMI K. , HIZUKURI S. , OHFUJI T. , OGATA K. "Some properties and the inclusion behavior of branched cyclodextrins" , Chem. Pharm. Bull. 36 , 2176-2185 (1988 )

78 PITHA J. , MILECKI J. , FALES H. , PANNELL L. , UEKAMA K. "Hydroxypropyl-beta-cyclodextrin: preparation and characterization; effects on solubility of drugs" , Int. J. Pharm. 29 , 73-82 (1986 )

79 LOFTSSON T. , ÓLAFSDÓTTIR B.J. , FRIDRIKSDÓTTIR H. "Comparative study on inclusion complexation of acetylsalicylic acid, cholecalciferol and melphalan with beta- and gamma-cyclodextrin and some of their derivatives" , Acta Pharm. Nord. 2 , 303 ff (1990 )

80 HARIA M. , BALFOR J.A. "Methylprednisolone aceponate: A review of its pharmacological properties and therapeutic potential in the topical treatment of eczema" , Clin. Immunother. 3 , 241-253 (1995 )

81 SCHUNACK W. , MAYER K. , HAAKE M. Arzneistoffe: Lehrbuch der Pharmazeutischen Chemie , Vieweg Braunschweig 1983 , S. 437

82 KARLSON P. Kurzes Lehrbuch der Biochemie für Mediziner und Naturwissenschaftler , Georg Thieme Verlag Stuttgart 1988 , S. 378

83 BUDDECKE E. Grundriss der Biochemie , Walter de Gruyter Berlin 1985 , S. 418

84 SMITH E.L. , PINCUS S.H. , DONOVAN L. , HOLICK M.F. "A novel approach for the evaluation and treatment of psoriasis" , J. Am. Acad. Dermatol. 19 , 516-528 (1988 )

85 MURDOCH D. , CLISSOLD S.P. "Calcipotriol: A Review of its Pharmacological Properties and Therapeutic Use in Psoriasis Vulgaris" , Drugs 43 , 415-429 (1992 )

86 WOZEL G. , BARTH J. "Vergleichende Untersuchungen über die Wirksamkeit topischer Steroide bei Psoriasis" , Dermatol. Monatsschr. 172 , 550-553 (1986 )

87 CRAMER F. "Einschlußverbindungen" , Angew. Chem. 64 , 437-447 (1952 )

88 HIRAYAMA F. , UEKAMA K. , KOINUMA H. "Molecular dynamics of prostaglandin F2alpha-cyclodextrin complexes in aqueous solution" , Chem. Pharm. Bull. 28 , 1975 -1980 (1980 )

89 SCHURIG V. , NOWOTNY H. -P. Angew. Chem. , 102 , 969 (1990 )

90 BETZEL C. , SAENGER W. , HINGERTY B.E. , BROWN G.M. "Circular and flip-flop hydrogen bonding in beta-cyclodextrin undecahydrate: A neutron diffraction study" , J. Am. Chem. Soc. 106 , 7545-7557 (1984 )

91 UEKAMA K. "Cyclodextrin derivates as drug carriers" , Pharm. Tech. Jpn. 4 (2), 183-189 (1988 )

92 BREWSTER M.E. , SIMPKINS J.W. , HORA M.S. , STERN W.C. , BODOR N. "The potential use of cyclodextrins in parenteral formulations" , J. Parent. Sci. Technol. 43 , 231-240 (1989 )

93 YAMAMOTO M. , YOSHIDA A. , HIRAYAMA F. , UEKAMA K. "Some physicochemical properties of branched beta-cyclodextrins and their inclusion characteristics" , Int. J. Pharm. 49 , 163-171 (1989 )

94 HIRAYAMA F. , HIRASHIMA N. , ABE K. , UEKAMA K. , IJITSU T. , UENO M. "Utilization of diethyl-beta-cyclodextrin as a sustained-release carrier for isosorbide dinitrate" , J. Pharm. Sci. 77 , 233-236 (1988 )

95 UEKAMA K. , HORIUCHI Y. , IRIE T. , HIRAYAMA F. "O-Carboxymethyl-O-ethylcyclomaltoheptaose as a delayed-release-type drug carrier: Improvement of the oral bioavailability of diltiazem in the dog" , Carbohydr. Res. 192 , 323-330 (1989 )

96 ADACHI H. , IRIE T. , HIRAYAMA F. , UEKAMA K. "Stabilization of Prostaglandin E1 in fatty alcohol propylene glycol ointment by acidic cyclodextrin derivative, O-Carboxymethyl-O-ethyl-beta-cyclodextrin" , Chem. Pharm. Bull. 40 , 1586-1591 (1992 )

97 SZEJTLI V.J. , FENYVESI E. , ZSADON B. "Cyclodextrinpolymere" , Stärke 30 , 127-131 (1978 )

98 UEKAMA K. , OTAGIRI M. , IRIE T. , SEO H. , TSURUOKA N. "Improvement of dissolution and absorption characteristics of phenytoin by a water-soluble beta-cyclodextrin-epichlorhydrin polymer" , Int. J. Pharm. 23 , 35-42 (1985 )

99 SZEJTLI J. "Complexing properties of substituted cyclodextrins and cyclodextrin polymers in aqueous solutions" , Carbohydrate Polymers 2 , 305-306 (1982 )

100 DUCHÉNE D. , WOUESSIDJEWE D. "Pharmaceutical uses of cyclodextrins and derivatives" , Drug Dev. Ind. Pharm. 16 , 2487-2499 (1990 )

101 HIRAYAMA F. , UEKAMA K. "Methods of investigating and preparing inclusion compounds" In: DUCHÊNE D. (Herausgeber), Cyclodextrins and their industrial uses , Editions de Santé Paris 1987 , SS. 131-172

102 MARQUES H.M.C. "Preparation of complexes. Evidence for complex formation." Rev. Port. Farm. 44 , 157-163 (1994 )

103 SERPELLONI M. , MENTIK L. "Industrial preparation methods of beta-cyclodextrin compounds" , In: Hedges A.R. (Herausgeber), Minutes of the Sixth International Symposium on Cyclodextrins , Edition de Santé Paris 1992 , SS. 288-293

104 JONES S.P. , GRANT D.J.W. , HADGRAFT J. , PARR G.D. "Cyclodextrins in the Pharmaceutical Sciences / Part I: Preparation, Structure and Properties of Cyclodextrins and Cyclodextrin Inclusion Compounds" , Acta Pharm. Technol. 30 , 213-223 (1984 )

105 SAENGER W. "Cyclodextrin-Einschlußverbindungen in Forschung und Industrie" , Angew. Chem. 92 , 343-361 (1980 )

106 TOKUMURA T. , UEDA H. , TSUSHIMA Y. , KASAI M. , KAYANO M. , AMADA I. , NAGAI T. "Inclusion complexes of cinnarizine with beta-Cyclodextrin in aqueous solution and in the Solid State" , Chem. Pharm. Bull. 32 , 4179-4184 (1984 )

107 DEMARCO P.V. , THAKKAR A.L. "Cyclohepta-amylose inclusion complexes. A proton magnetic resonance study" , J. Chem. Soc. Chem. Commun. , S.2ff (1970 )

108 SZEJTLI J. Cyclodextrines and their inclusion complexes , Akademiai Kiado Budapest 1982 , SS. 162-180

109 UEKAMA K. , SAKAI A. , ARIMORI K. , OTAGIRI M. , SAITO H. "Different mode of prednisolone within alpha-, beta- and gamma-cyclodextrins in aqueous solution and in solid state" , Pharm. Acta Helv. 60 , 117-122 (1985 )

110 LIU F.-Y. , KILDSIG D.O. , MITRA A.K. "Beta-cyclodextrin/steroid complexation: Effect of steroid structure on association equilibria" , Pharm. Res. 7 , 869-874 (1990 )

111 OTAGIRI M. , IMAI T. , Hirayama f. , uekama k. , YAMASAKI m. "Inclusion complex formations of the antiinflammatory drug flurbiprofen with cyclodextrins in aqueous solution and in solid state" , Acta Pharm. Suec. 20 , 11-20 (1983 )

112 DIN 51005 Thermische Analyse (TA): Begriffe , Beuth Verlag , Ausgabe 08/1993 , 6 Seiten

113 WIDMANN G. , RIESEN R. Thermoanalyse , Hüthig Verlag Heidelberg 1987 , S. 16

114 HIGUCHI T. , CONNERS K.A. "Phase-solubility techniques" , Adv. Anal. Chem. Instr. 4 , 117-212 (1965 )

115 MANOR P.C. , SAENGER W. "Topography of Cyclodextrin Inclusion Complexes / III. Crystal and Molecular Structure of Cyclohexaamylose Hexahydrate, the (H2O)2 Inclusion Complex" , J. Am. Chem. Soc. 96 , 3630 ff (1974 )

116 NAKAI Y. , YAMAMOTO K. , TERADA K. , AKIMOTO K. "The dispersed states of medicinal molecules in ground mixtures with alpha- or beta-cyclodextrin" , Chem. Pharm. Bull. 32 , 685-691 (1984 )

117 UEDA H. , NAGAI T. "Solid-state nuclear magnetic resonance spectroscopy and raman spectroscopy of the inclusion compound of tolbutamide with beta-cyclodextrin" , Chem. Pharm. Bull. 29 , 2710-2714 (1981 )

118 KEIPERT S. , FEDDER J. , BOHM A. , HANKE B. "Interactions between cyclodextrins and pilocarpine - as an example of a hydrophilic drug" , Int. J. Pharm. , 142 , 153-162 (1996 )

119 MOYANO J.R. , ARIAS M.J. , GINES J.M. , RABASCO A.M. "Dissolution behavior of oxazepam in presence of cyclodextrins - evaluation of oxazepam-dimeb binary system" , Drug Dev. Ind. Pharm. , 23 , 379-385 (1997 )

120 BRONAUGH R.L. "Determination of percutaneous absorption by in vitro techniques" In: Bronaugh R.L. and Maibach H.I. (Herausgeber ), Percutaneous Absorption. Mechanisms-Methodology-Drug Delivery . Marcel Dekker , New York 1989 , SS. 239-258

121 BABAR A. , BHANDARI R.D. , PLAKOGIANNIS F.M. "In vitro release studies of chlorpheniramine maleate from topical bases using cellulose membrane and hairless mouse skin" , Drug Dev. Ind. Pharm. 17 , 1027-1040 (1991 )

122 HADGRAFT J.W. , WALTERS K.A. , WOTTON P.K. "Facilitated percutaneous absorption: a comparison and evaluation of two in vitro models" , Int. J. Pharm. 32 , 257-263 (1986 )

123 RICHTER B. Biopharmazeutische in vitro Untersuchungen zum Stofftransport durch künstliche Membranen , Dissertation der Humboldt Universität zu Berlin 1988

124 HIGUCHI W.J. "Diffusional models useful in biopharmaceutics / drug release rate processes" , J. Pharm. Sci. 56 , 315-324 (1967 )

125 HIGUCHI T. "Physical chemical analysis of percutaneous absorption process from creams and ointments" , J. Soc. Cosmet. Chem. 11 , 85-93 (1960 )

126 NIEDNER R. , ZIEGENMEYER J. Dermatika , Wissenschaftliche Verlagsgesellschaft Stuttgart 1992 , SS. 288-290

127 LOTH H. , HAILER M. "Parameter-Bestimmung bei der Arzneistoffliberation aus Salben in Membranmodellen" , Acta Pharm.Technol. , 29 , 97-102 (1983 )

128 LIPPOLD B.C. "Kutane Resorption - Möglichkeiten, Modelle, Beeinflussung" , Acta Pharm. Technol. 27 , 1-5 (1981 )

129 YALKOWSKI S.H. , FLYNN G.L. "Correlation and prediction of mass transport across membranes II: Influence of vehicle polarity on flux from solutions and suspensions" , J. Pharm. Sci. 63 , 1276-1285 (1974 )

130 Wild T. Einfluß der physiko-chemischen Eigenschaften von Arzneistoffen und Vehikeln auf die Permeabilität der menschlichen Hornschicht , Dissertation, Universität Saarbrücken 1988

131 US PHARMACOPEIA USP 23 NF 18 1995 Transdermal Delivery Systems - General Drug Release Standards, Dissolution <724> , S. 1791

132 SWR 37 Steuerungs- und Auswertungssoftware Rheologie , Mettler Toledo , 1993

133 SUCKER W. , SPEISER H. , FUCHS H. Pharmazeutische Technologie , Stuttgart Thieme , 1991 , SS. 2-3

134 FRANKE P. , HOFFMANN K. , TÄUBER U. , KEIPERT S. "In-vitro-Liberationsstudien aus Steroidsalben" , Pharm. Ind. 58 , 1152-1156 (1996 )

135 GRID Software Version 11 , Molecular Discovery Ltd. , Oxford, England

136 GOODFORD P.J. "A computational procedure for determining energetically favorable binding sites on biologically important macromolecules" , J. Med. Chem. 28 , 849-855 (1985 )

137 ANZALI S. Molecular Modelling-Studien zum Herzglykosid-Rezeptorareal an der Na+-ATPase , Dissertation, Freie Universität Berlin (1993 )

138 CRUCIANI G. , WATSON K.A. "Comparative Molecular Field Analysis Using GRID Force-Field and GOLPE Variable Selection Methods in a Study of Inhibitors of Glycogen Phosphorylase b" , J. Med. Chem. 37 , 2589-2601 (1994 )

139 JENDRETZKY U. Molecular-Modelling-Untersuchungen zum Bindungsverhältnis von 5-HT2alpha-rezeptor-affinen Substanzen , Dissertation, Freie Universität Berlin (1993 )

140 UEKAMA K. , OTAGIRI M. "Cyclodextrins in drug carrier systems" , CRC Crit. Rev. Ther. Drug Carrier Syst. 3 , 1-40 (1987 )

141 KIKUCHI M. , Hirayama f. , uekama k. "Improvement of oral and rectal bioavailabilities of carmofur by methylated beta-cyclodextrin complexations" , Int. J. Pharm. 38 , 191-198 (1987 )

142 CASU B. , REGGIANI M. "Methylated cycloamyloses (cyclodextrins) and their inclusion properties" , Carbohydr. Res. 76 , 59-66 (1979 )

143 BRAUNS U. , MÜLLER B.W. beta-Cyclodextrin inclusion compounds for pharmaceuticals, Patent von Janssen Pharmaceutica N. V. , DE 3346123 A1 850627 (1983 )

144 OKADA Y. , TACHIBANA M. , KOIZUMI K. "Solubilization of lipid-soluble vitamins by complexation with glucosyl-beta-cyclodextrin" , Chem. Pharm. Bull. 38 , 2047-2049 (1990 )

145 GLOMOT F. , BENKERROUR L. , DUCHÊNE D. , POELMAN M.-C. "Improvement in availability and stability of a dermocorticoid by inclusion in beta-cyclodextrin" , Int. J. Pharm. 46 , 49-55 (1988 )

146 SHANKLAND N. , PEARSON A. , JOHNSON J.R. , SALOLE E.G. "The influence of beta-cyclodextrin on the release of hydrocortisone from a topical cream base" , J. Pharm. Pharmacol. 37 Supp, 107-114 (1985 )

147 ASCHE H. , ESSIG D. , SCHMIDT P.C. Technologie von Salben, Suspensionen und Emulsionen (ein Seminar der APV, Darmstadt, Sept. 1982) , Wissenschaftliche Verlagsgesellschaft Stuttgart 1984 , S. 174

148 FUNK O. , SCHWABE L. , FRÖMMING K.-H. "Freeze-dried preparations of ketoprofen and heptakis-(2,6-O-dimethyl)- beta-cyclodextrin" , Drug Dev. Ind. Pharm. 20 , 1957 -1969 (1994 )

149 BARRY B.W. Dermatological Formulations, Percutaneous Resorption , Marcel Dekker Inc. New York 1983 , S. 73

150 ORIENTI I. , ZECCHI V. , BERTASI V. , FINI A. "Release of ketoprofen from dermal bases in presence of cyclodextrins: effect of the affinity constant determined in semisolid vehicles" , Arch. Pharm. 324 , 943-947 (1991 )

151 FRÖMMING K.H. , MEHNERT W. , BADY P. , KRAUS C. , STEIN M. , WEDELICH V. "Competitive reactions of cyclodextrin inclusion compounds" , In: Duchêne D. (Herausgeber), Minutes International Symposium Cyclodextrins, 5th (1990) , Edition Santé Paris 1990 , SS. 392-398

152 SZETLI J. ," BÁNKYELÖD E Inclusion complexes of unsaturated fatty-acids with amylose and cyclodextrin" , Stärke 27 , 368-376 (1975 )

153 OKADA Y. , KOIZUMI K. , OGATA K. , OHFUJI T. "Inclusion Complexes of Lipids with Branched Cyclodextrins" , Chem. Pharm. Bull. 37 , 3096-3099 (1989 )

154 PREISS A. Beeinflussung der Arzneistofffreisetzung aus Salben und der Pentration in Humanhaut durch Cyclodextrine , Dissertation, Freie Universität Berlin 1993

155 COUARRAZE G. , WEPIERRE J. "Topical applications of liposomes" , In: Puisieux F., Couvreur P., Delattre J., Devissaguet J.-P. (Herausgeber), Liposomes, New systems and new trends in their applications , Editions de Santé Paris 1995 , SS. 615-635

156 HELENIUS A. , SOMONS K. "Solubilization of membranes by detergents" , Biochim. Biophys. Acta 415 , 29-79 (1975 )

157 WOHLRAB W. , LASCH J. , TAUBE K.-M. , WOZNIAK K.-D. "Hautpermeation von liposomal inkorporiertem Hydrocortison" , Pharmazie 44 , 333 ff (1989 )

158 MEZEI M. , GULASEKHARAM V. "Liposomes - a selective drug delivery system for the topical route of administration" , Life Sci. 26 , 1473-1477 (1980 )

159 LASIC D.D. Liposomes: from Physics to Application , Elsevier Amsterdam 1993 , Ch. 4, SS.109 ff

160 KIRKHUS B. , OLSEN W.M. , CLAUSEN O.P.F. "A comparison between the epidermal regenerative responses provoked by a skin irritant and a tumor promoter using anti-BrdUrd/DNA flow cytometry" , Carcinogenesis 12 , 833-837 (1991 )

161 LINDBERG M. , FORSLIND B., SAGSTRÖM S. , ROOMANS G.M. "Elemental changes in guinea pig epidermis at repeated exposure to sodium lauryl sulfate" , Acta Derm. Venereol. 72 , 428-431 (1992 )

162 HAIGH J.M. , SMITH E.W. "The selection and use of natural and synthetic membranes for in vitro diffusion experiments" , Eur. J. Pharm. Sci. 2 , 311-330 (1994 )

163 BRONAUGH R.L. , STEWART R.F. , CONGDON E.R. "Methods for in vitro percutaneous absorption studies / II. Animal models for human skin" , Toxicol. Appl. Pharmacol. 62 , 481-488 (1982 )

164 SZEJTLI J. , BOLLA K. , NAGY G. UK Patent Applicaton GB 2037773 A 1989

165 GELDER T. Herstellung und Charakterisierung der Einschlußverbindungen von beta-Cyclodextrinen und Dimeb mit Vitamin A Acetat , Dissertation, Freie Universität Berlin 1988

166 VENTURA C.A. , PUGLISI G., GIAMMONA G. , BOTTINO F.A. "Comparative study on inclusion compounds of 4-biphenylacetic acid with beta-cyclodextrin, hydroxypropylated-beta-cyclodextrins, and methylated-beta-cyclodextrins" , Drug Dev. Ind. Pharm. 20 , 2245-2265 (1994 )

167 KOIZUMI K. , OKADA Y. , KUBOTA Y. , UTAMURA T. "Inclusion complexes of poorly water-soluble drugs with glucosyl-cyclodextrins" , Chem. Pharm. Bull. 35 , 3413-3418 (1987 )

168 SACHS, L. Statistische Methoden , Springer Verlag Berlin Heidelberg New York 1982 , SS. 44-58


[Titelseite] [Abkürzungsverzeichnis] [1] [2] [3] [4] [5] [Bibliographie] [Danksagung] [Lebenslauf]

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.

DiDi DTD Version 1.1
a subset from ETD-ML Version 1.1
Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML - Version erstellt am:
Wed Feb 17 15:43:41 1999